United States v. Okafor

District Court, District of Columbia·Decided September 23, 2024·No. Criminal No. 2023-0116·Published

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA

UNITED STATES OF AMERICA, Plaintiff, v. Criminal Action No. 23-116 (JDB)

NDUBUISI JOSEPH OKAFOR, Defendant.

MEMORANDUM OPINION

Defendant Ndubuisi Okafor faces charges centered around allegations that he used his medical license to illegally distribute controlled substances. In particular, he is charged with conspiracy to unlawfully distribute controlled substances in violation of 21 U.S.C. § 846; maintaining drug-involved premises and aiding and abetting in the same in violation of 21 U.S.C. § 856(a)(1) and 18 U.S.C. § 2; and twenty-seven counts of unlawful distribution of controlled substances and aiding and abetting in the same in violation of 21 U.S.C. § 841(a)(1) and 18 U.S.C. § 2. See Superseding Indictment [ECF No. 34] (“Indictment”) at 5–9. Trial is scheduled for October of this year.

Currently before the Court is a raft of motions from both sides. Okafor moves to dismiss the indictment and to suppress certain evidence. See Okafor’s Mot. to Dismiss With Mem. of P. & A. [ECF No. 41] (“Mot. to Dismiss”); Mot. to Suppress Evid. Derived From Computers, Phone, iCloud and/or Social Media Acct. Searches [ECF No. 40] (“Mot. to Suppress”). 1 The government counters with motions of its own, seeking permission to use certain evidence at trial and asking

1 Okafor also filed a motion asking the Court to exclude one piece of evidence the government sought permission to introduce in one of its motions. See Def.’s Mot. in Lim. 1 Concerning Alleged Victim J.V. [ECF No. 46]. Because this motion operates in effect as an opposition to the government’s motion, the Court treats it as such.

the Court to preclude Okafor from engaging in trial tactics the government views as inappropriate. See U.S.’s Mot. to Admit Evid. Intrinsic to the Charged Conduct and Pursuant to Fed. R. Evid. 404(b) [ECF No. 37] (“Mot. to Admit Evid.”); U.S.’s Suppl. to its Mot. to Admit Intrinsic Evid. & Pursuant to Fed. R. Evid. 404(b) [ECF No. 63] (“Suppl. to Mot. to Admit Evid.”); U.S.’s Mot. in Lim. to Impeach the Def. with his Prior Conviction Pursuant to Fed. R. Evid. 609 & Specific Instances of Conduct Under Rule 608 [ECF No. 39] (“Mot. to Impeach”); U.S.’s Omnibus Mot. in Lim. [ECF No. 38] (“Omnibus Mot.”).

The motions are now fully briefed and ripe for resolution.

Background 2

Okafor, a District of Columbia-based doctor, headed a national drug distribution ring beginning around May 2021 and ending upon his arrest in April 2023. See Indictment at 5; Mot. to Admit Evid. at 1. To do so, Okafor leveraged his status as a physician, prescribing oxycodone and promethazine with codeine—both controlled substances under the Controlled Substances Act, 21 U.S.C. § 801 et. seq.; see 21 C.F.R. §§ 1308.12(b)(1)(xiv), 1308.15(c)(1)—to co-conspirators and individual patients in pursuit of profit rather than treatment. See Indictment at 5.

In broad strokes, the scheme went something like this. Co-conspirators sent Okafor prescription requests with patients’ names, dates of birth, pharmacy addresses, and drug types and quantities. Indictment at 6. Despite knowing that the patient information was frequently false, Okafor would oblige. Id. at 7. In exchange for each prescription, the co-conspirators would pay Okafor cash in the range of $180 to $300. Id. The co-conspirators would then use or sell the substances. Id.

2 The following summary is based on the factual assertions in the indictment and the government’s motions, which the Court relates solely as a summary of what the government intends to prove at trial. The Court’s reliance on these alleged facts for purposes of this opinion should not be construed as an endorsement of their truth, which is a determination for the jury.

To avoid detection by state authorities, Okafor often issued the prescriptions across state lines, and sometimes prescribed the same medications to the same purported patients in many states and listing different home addresses—or, conversely, to the same co-conspirators in the same states under different names. Id.; Mot. to Admit Evid. at 6–7, 9. Okafor frequently changed the listed first name to avoid detection while retaining the real patient’s last name, in the hope that otherwise skeptical pharmacists would think the co-conspirators were merely picking up family members’ prescriptions. Mot. to Admit Evid. at 6. All told, Okafor issued prescriptions in this manner in at least thirty-seven states and the District of Columbia, despite being licensed to prescribe only in the District of Columbia. Id. at 1, 3, 22.

As to the individual patients, the story is simpler: from his medical office, Okafor would prescribe large quantities of controlled substances “on demand” to patients without any meaningful examination, and again often in exchange for cash payment. Id. at 2, 6, 9. He would sometimes issue these prescriptions to his patients’ real names and other times to pseudonyms to enable them to collect more prescriptions than would otherwise be possible. Id. at 8–9. For one patient, for instance—whom the government intends to present as a witness at trial—Okafor wrote at least nineteen oxycodone and promethazine with codeine prescriptions within a three-month period. Id.

The government indicted and arrested Okafor in April 2023 and filed a superseding indictment a year later.

Analysis

I. Motion to Dismiss Okafor moves to dismiss the indictment on two primary grounds: that the Controlled Substances Act is unconstitutionally vague as applied to him, and that it in fact cannot apply to him given his status as a registered doctor. Each ground for dismissal can be rejected easily. In

ruling on each, the Court is mindful that it must presume the truth of the government’s proffered facts. United States v. Park, 938 F.3d 354, 358 (D.C. Cir. 2019); see also United States v. Ballestas, 795 F.3d 138, 148–49 (D.C. Cir. 2015).

A. The law is not unconstitutionally vague as applied to Okafor.

Okafor first contends that the Controlled Substances Act is unconstitutionally vague as applied to him. Mot. to Dismiss at 4. The argument draws on the precept that a conviction violates due process “if the statute under which it is obtained fails to provide a person of ordinary intelligence fair notice of what is prohibited, or is so standardless that it authorizes or encourages seriously discriminatory enforcement.” Holder v. Humanitarian L. Project, 561 U.S. 1, 18 (2010) (quoting United States v. Williams, 553 U.S. 285, 304 (2008)). But to survive such a challenge, a statute’s scope need not “be clear in every application.” Id. at 21; see also United States v. Sandlin, 575 F. Supp. 3d 16, 30 (D.D.C. 2021). Instead, the statute need only provide fair notice “as applied to the particular facts at issue.” Humanitarian L. Project, 561 U.S. at 18. So long as Okafor’s conduct was “clearly proscribed,” he “cannot complain of the vagueness of the law as applied to the conduct of others.” Id. at 18–19 (quoting Vill. of Hoffman Ests. v. Flipside, Hoffman Ests., Inc., 455 U.S. 489, 495 (1982)).

Okafor’s alleged conduct was clearly proscribed. As relevant here, the Controlled Substances Act makes it a federal crime to “knowingly or intentionally” distribute or dispense a controlled substance, “[e]xcept as authorized.” 21 U.S.C. § 841(a). There is no dispute that Okafor in fact distributed or dispensed controlled substances. This case therefore turns on the authorization exception, under which registered doctors like Okafor are “authorized” to prescribe controlled substances without violating the statute, see id. § 822(b), so long as they issue the prescription “for a legitimate medical purpose” and “acting in the usual course of [their]

professional practice,” 21 C.F.R. § 1306.04(a). If they prescribe controlled substances outside of those guardrails, however, registered doctors are “subject to the penalties provided for violations” of the Controlled Substances Act. Id.

Free access — add to your briefcase to read the full text and ask questions with AI

United States v. Okafor, (D.D.C. 2024).

United States v. Okafor (United States v. Okafor) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Screws v. United States
325 U.S. 91 (Supreme Court, 1945)
United States v. Moore
423 U.S. 122 (Supreme Court, 1975)
Dalia v. United States
441 U.S. 238 (Supreme Court, 1979)
Hoffman Estates v. Flipside, Hoffman Estates, Inc.
455 U.S. 489 (Supreme Court, 1982)
United States v. Leon
468 U.S. 897 (Supreme Court, 1984)
Luce v. United States
469 U.S. 38 (Supreme Court, 1984)
Old Chief v. United States
519 U.S. 172 (Supreme Court, 1997)
United States v. Grubbs
547 U.S. 90 (Supreme Court, 2006)
United States v. Williams
553 U.S. 285 (Supreme Court, 2008)
United States v. Burgess
576 F.3d 1078 (Tenth Circuit, 2009)
United States v. Mathis, Eddie J.
216 F.3d 18 (D.C. Circuit, 2000)
United States v. Bowie, Juan
232 F.3d 923 (D.C. Circuit, 2000)
United States v. Whitmore, Gerald F.
359 F.3d 609 (D.C. Circuit, 2004)
United States v. Hemphill
514 F.3d 1350 (D.C. Circuit, 2008)
United States v. Joseph R. Jackson
627 F.2d 1198 (D.C. Circuit, 1980)
Messerschmidt v. Millender
132 S. Ct. 1235 (Supreme Court, 2012)
United States v. Ron Morrison
98 F.3d 619 (D.C. Circuit, 1996)
United States v. Zolton Williams
205 F.3d 23 (Second Circuit, 2000)
United States v. Robert A. Kuzlik
468 F.3d 972 (Seventh Circuit, 2006)
United States v. Khanu
664 F. Supp. 2d 80 (District of Columbia, 2009)